Health

  • Home
  • Business
    • Internet
    • Market
    • Stock
  • Parent Category
    • Child Category 1
      • Sub Child Category 1
      • Sub Child Category 2
      • Sub Child Category 3
    • Child Category 2
    • Child Category 3
    • Child Category 4
  • Featured
  • Health
    • Childcare
    • Doctors
  • Home
  • Business
    • Internet
    • Market
    • Stock
  • Downloads
    • Dvd
    • Games
    • Software
      • Office
  • Parent Category
    • Child Category 1
      • Sub Child Category 1
      • Sub Child Category 2
      • Sub Child Category 3
    • Child Category 2
    • Child Category 3
    • Child Category 4
  • Featured
  • Health
    • Childcare
    • Doctors
  • Uncategorized

Tuesday, April 1, 2025

Experimental women's cancer drug boosts survival rates in notable study

 April 01, 2025     Health, Health News Today on Fox News     No comments   

A new drug is showing promise in tackling treatment-resistant ovarian cancer.

Relacorilant, the drug tested in a phase 3 ROSELLA trial with Corcept Therapeutics in California, was found to improve overall survival and progression of the disease when matched with a chemotherapy drug called nab-paclitaxel.

The ROSELLA trial, conducted in collaboration with The GOG Foundation, analyzed 381 patients around the world, including the U.S., Europe, South Korea, Brazil, Argentina, Canada and Australia, according to a press release.

AI DETECTS OVARIAN CANCER BETTER THAN HUMAN EXPERTS IN NEW STUDY

The large, randomized phase 3 study revealed a 30% reduction in risk of disease progression in patients with platinum-resistant ovarian cancer, compared to those just treated with nab-paclitaxel. (Some types of chemotherapy contain the element platinum.)

The researchers also noted "significant improvement" in overall survival with this combination of drugs.

Relacorilant, which is administered as an oral pill, was reportedly "well-tolerated" by patients without increased side effects.

The drug is administered by mouth one day before, the day of and one day after nab-paclitaxel therapy, which is given via infusion every week.

The findings will be presented at a medical conference later this year, researchers say. Results from the Phase 2 were published in the Journal of Clinical Oncology in 2023.

OVARIAN CANCER TREATMENT ON FAST TRACK FOR FDA APPROVAL AS CHEMO ALTERNATIVES EMERGE: 'WE'RE MAKING PROGRESS'

Ovarian cancer is the fifth most common cause of cancer death in women and is the deadliest of gynecologic cancers, according to the Ovarian Cancer Research Alliance.

Alexander B. Olawaiye, MD, director of gynecological cancer research at Magee-Women’s Hospital at the University of Pittsburgh and principal investigator in the ROSELLA trial, discussed the results with Fox News Digital.

Olawaiye echoed that this new agent is the "first of its kind" in the battle against cancers that don't have many treatment options.

"That’s what makes the findings of this study really exciting, because it did show a very significant improvement in both progression-free survival and overall survival," he said.

OVARIAN CANCER SIGNS, SYMPTOMS, DIAGNOSIS AND TREATMENT OPTIONS

The expert shared his gratitude to his research team, mentioning that they "never stopped trying" for women undergoing treatment.

"I want to congratulate the women that are being treated for ovarian cancer — first, for helping us to do this trial and second, for the potential that we may now have another option on the block."

Dr. Brian Slomovitz, director of gynecologic oncology and co-chair of the Cancer Research Committee at Mount Sinai Medical Center in Miami Beach, Florida, also commented on these findings in an interview with Fox News Digital.

"We know ovarian cancer is very, very difficult to treat, particularly in those patients who have a disease that’s resistant to the standard chemotherapies," he said.

"For a long time, we've been trying to find treatments that can help patients not only keep the disease away longer, but also live longer. And most of the trials, unfortunately, have been negative."

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Slomovitz, a member of The GOG Foundation, said he considers the ROSELLA trial an "opportunity to use a unique drug" that has shown "positive, encouraging results."

"A 30% decrease in risk of recurrence and a 31% decreased risk of death is promising," he stated.

"To see data like this is refreshing, and it represents something that's exciting for our patients who suffer from ovarian cancer."

Olawaiye shared his hope for the treatment to receive clinical approval "pretty soon."

For more Health articles, visit www.foxnews.com/health

As research and technology advance, various cancer treatments have surfaced in the last several years.

Olawaiye commented that the past two decades have been a "very exciting time," as there’s been an "explosion of approvals" for cancer therapies.

"Today's news about Relacorilant is just another addition," he said.



from Health News Today on Fox News https://ift.tt/woMJq9Y
  • Share This:  
  •  Facebook
  •  Twitter
  •  Google+
  •  Stumble
  •  Digg
Email ThisBlogThis!Share to XShare to Facebook

Related Posts:

  • FOX NEWS: Rapid coronavirus antigen tests may give false positives, FDA warns Rapid coronavirus antigen tests may give false positives, FDA warns The Food and Drug Administration (FDA) warned about the possibility of false p… Read More
  • Coronavirus infects the mouth. Could that explain patients' taste loss?The coronavirus SARS-CoV-2 can infect cells in the mouth, which may spur the virus's spread both in the body and to other people, according to a preli… Read More
  • FOX NEWS: Type 2 diabetes drug recalled over concerns medication contaminated with possible carcinogen Type 2 diabetes drug recalled over concerns medication contaminated with possible carcinogen Metformin, a medication to treat type 2 diabetes, is … Read More
  • Rapid coronavirus antigen tests may give false positives, FDA warnsThe Food and Drug Administration (FDA) warned about the possibility of false positives that can occur when using rapid antigen tests to detect coronav… Read More
  • FOX NEWS: Coronavirus infects the mouth. Could that explain patients' taste loss? Coronavirus infects the mouth. Could that explain patients' taste loss? The coronavirus SARS-CoV-2 can infect cells in the mouth, which may spur t… Read More
Newer Post Older Post Home

0 comments:

Post a Comment

Popular Posts

  • Helping Stroke Patients Regain Movement in their Hands
    By BY PAM BELLUCK from NYT Health https://ift.tt/6uNPHMD
  • FOX NEWS: Woman’s ‘baby bump’ turns out to be two ovarian tumors
    Woman’s ‘baby bump’ turns out to be two ovarian tumors A 49-year-old woman who struggled with fertility thought she might be pregnant w...
  • Ozempic ‘microdosing’ is the new weight-loss trend: Should you try it?
    A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. With approximately 70% of...

Recent Posts

Categories

  • Health News Today on Fox News
  • FOX NEWS
  • Fox News : Health
  • Health
  • Health News Today on Fox News
  • Healthy tips
  • NYT

Unordered List

Pages

  • Home

Text Widget

Blog Archive

  • July 2025 (60)
  • June 2025 (75)
  • May 2025 (88)
  • April 2025 (84)
  • March 2025 (88)
  • February 2025 (70)
  • January 2025 (72)
  • December 2024 (81)
  • November 2024 (70)
  • October 2024 (82)
  • September 2024 (75)
  • August 2024 (82)
  • July 2024 (79)
  • June 2024 (74)
  • May 2024 (73)
  • April 2024 (78)
  • March 2024 (75)
  • February 2024 (78)
  • January 2024 (78)
  • December 2023 (60)
  • November 2023 (80)
  • October 2023 (74)
  • September 2023 (75)
  • August 2023 (85)
  • July 2023 (67)
  • June 2023 (58)
  • May 2023 (100)
  • April 2023 (105)
  • March 2023 (118)
  • February 2023 (84)
  • January 2023 (87)
  • December 2022 (69)
  • November 2022 (64)
  • October 2022 (78)
  • September 2022 (74)
  • August 2022 (110)
  • July 2022 (109)
  • June 2022 (127)
  • May 2022 (95)
  • April 2022 (109)
  • March 2022 (140)
  • February 2022 (138)
  • January 2022 (170)
  • December 2021 (182)
  • November 2021 (213)
  • October 2021 (506)
  • September 2021 (539)
  • August 2021 (564)
  • July 2021 (590)
  • June 2021 (556)
  • May 2021 (544)
  • April 2021 (310)
  • March 2021 (331)
  • February 2021 (301)
  • January 2021 (326)
  • December 2020 (521)
  • November 2020 (403)
  • October 2020 (537)
  • September 2020 (554)
  • August 2020 (431)
  • July 2020 (647)
  • June 2020 (610)
  • May 2020 (659)
  • April 2020 (681)
  • March 2020 (729)
  • February 2020 (564)
  • January 2020 (483)
  • December 2019 (396)
  • November 2019 (416)
  • October 2019 (526)
  • September 2019 (486)
  • August 2019 (441)
  • July 2019 (394)
  • June 2019 (381)
  • May 2019 (510)
  • April 2019 (471)
  • March 2019 (560)
  • February 2019 (403)
  • January 2019 (530)
  • December 2018 (382)
  • November 2018 (378)
  • October 2018 (510)
  • September 2018 (297)
Powered by Blogger.

Report Abuse

Formulir Kontak



Search This Blog

Find Us On Facebook

Labels

  • Health News Today on Fox News
  • FOX NEWS
  • Fox News : Health
  • Health
  • Health News Today on Fox News
  • Healthy tips
  • NYT

Flickr Images

Most Popular

  • Helping Stroke Patients Regain Movement in their Hands
    By BY PAM BELLUCK from NYT Health https://ift.tt/6uNPHMD
  • FOX NEWS: Woman’s ‘baby bump’ turns out to be two ovarian tumors
    Woman’s ‘baby bump’ turns out to be two ovarian tumors A 49-year-old woman who struggled with fertility thought she might be pregnant w...
  • Ozempic ‘microdosing’ is the new weight-loss trend: Should you try it?
    A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. With approximately 70% of...
  • As eating disorders increase among college students, here's how parents can help: ‘Early intervention is key’
    While most of us have heard about the "Freshman 15" — the stereotypical first-year weight gain among college students — a growing ...
  • Psychedelics as potential mental health treatment are explored by Trump administration
    The Trump administration has expressed interest in exploring psychedelics for their potential in treating PTSD and other debilitating mental...
  • Pioneer of America's global HIV/AIDS program recalls hope after years of despair
    Through his office window at what was then one of Africa's few modern clinics dealing with HIV and AIDS , the man who now oversees the U...
  • Free COVID tests will again be available from US government starting next week
    The U.S. government is reactivating the program that mails free COVID-19 tests to Americans' homes upon request. Effective Sept. 25, h...
  • New COVID vaccine push is ‘anti-human,’ says Florida surgeon general: ‘Major safety concern’
    The new COVID-19 vaccine is now available at participating pharmacies and health care providers, and the Centers for Disease Control (CDC) ...
  • Mobile medical clinics bring health care directly to homeless veterans in 25 cities
    More than 35,000 veterans in America are homeless — and health care is not always their top priority.  The U.S. Department of Veterans Aff...
  • AI tech aims to help patients catch disease early even reverse their biological age
    In humanity's quest to live longer, healthier lives, technology — particularly artificial intelligence — is playing an ever-bigger role...

Sample Text

Copyright © 2025 Health | Powered by Blogger
Design by Hardeep Asrani | Blogger Theme by NewBloggerThemes.com | Distributed By Gooyaabi Templates